SCHEMBL2948865

SCHEMBL2948865

NCCCC[C@H](N)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3113278 1.00
SCHEMBL4537329 1.00
SCHEMBL13977639 0.97 GSR (0.43)
SCHEMBL6926014 0.97 GSR (0.43)
SCHEMBL29012720 0.97 GSR (0.43)
Hydrochloric Acid SCHEMBL30379993 0.97 GSR (0.43)
SCHEMBL555028 0.92
SCHEMBL8235057 0.92
SCHEMBL1044479 0.92
SCHEMBL11778128 0.89 TSHR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 164 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023225650-A1 LINKERS COUPLING FUNCTIONAL LIGANDS TO MACROMOLECULES OLIX US, INC. (US) 2023-11-23 WO claimed
US-20230372508-A1 LINKERS COUPLING FUNCTIONAL LIGANDS TO MACROMOLECULES OLIX US, INC. 2023-11-23 US claimed
US-20050261372-A1 Derivatives of glycinergic r(+)-2-amino-3-hydroxypropanoic acid ORAPHARMA, INC. 2005-11-24 US claimed
EP-1529030-A2 DERIVATIVES OF GLYCINERGIC R(+)-2-AMINO-3-HYDROXYPROPANOIC ACID Prestwick Pharmaceuticals, Inc. (US) 2005-05-11 EP claimed
WO-2004016580-A2 DERIVATIVES OF GLYCINERGIC R(+)-2-AMINO-3-HYDROXYPROPANOIC ACID PRESTWICK PHARMACEUTICALS, INC. (US) 2004-02-26 WO claimed
US-20260121095-A1 Advanced Ion Exchange Membranes And Applications Thereof WILLIAMS RICHARD KENT (US) 2026-04-30 US disclosed
EP-4713343-A2 ENZYMATICALLY ACTIVE DOMAINS FROM ANTI-STAPHYLOCOCCAL PHAGE PROTEINS Topaz Biosciences, Inc. (US) 2026-03-25 EP disclosed
US-20260078152-A1 ENZYMATICALLY ACTIVE DOMAINS FROM ANTI-STAPHYLOCOCCAL PHAGE PROTEINS TOPAZ BIOSCIENCES INC (US) 2026-03-19 US disclosed
US-20250340587-A1 INSOLUBLE SUPPORT FOR SOLID PHASE SYNTHESIS POLYPEPTIDE LABORATORIES HOLDING PPL AB (SE) 2025-11-06 US disclosed
WO-2025128460-A1 ADVANCED ION EXCHANGE MEMBRANES AND APPLICATIONS THEREOF WILLIAMS RICHARD KENT (US) 2025-06-19 WO disclosed
WO-2025101177-A1 IMPLANTABLE DEVICES AND METHODS FOR TREATING DEFECTIVE VENOUS VALVES BARD PERIPHERAL VASCULAR, INC. (US) 2025-05-15 WO disclosed
CN-119950467-A Application of N-beta-alanyl dopamine or salt thereof in preparation of product for preventing and treating hepatic fibrosis 首都医科大学 2025-05-09 CN disclosed
US-5176907-A Biocompatible and biodegradable poly (phosphoester-urethanes) THE JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE (US) 1993-01-05 US disclosed
WO-1992021698-A1 DETECTION OF COLLAGEN DEGRADATION $i(IN VIVO) WASHINGTON RESEARCH FOUNDATION (US) 1992-12-10 WO disclosed
EP-0502928-A1 METHODS OF DETECTING COLLAGEN DEGRADATION -i(IN VIVO). WASHINGTON RES FOUND (US) 1992-09-16 EP disclosed
US-5140103-A Peptide fragments containing HP and LP cross-links WASHINGTON RESEARCH FOUNDATION (US) 1992-08-18 US disclosed
WO-1991008478-A2 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO) WASHINGTON RESEARCH FOUNDATION (US) 1991-06-13 WO disclosed
US-4973666-A Peptide fragments containing HP and LP cross-links WASHINGTON RESEARCH FOUNDATION (US) 1990-11-27 US disclosed
EP-0394296-A1 ASSAY OF A BODY FLUID FOR MEASURING BONE RESORPTION. WASHINGTON RES FOUND (US) 1990-10-31 EP disclosed
WO-1989004491-A1 URINARY ASSAY FOR MEASURING BONE RESORPTION WASHINGTON RESEARCH FOUNDATION (US) 1989-05-18 WO disclosed